0001415889-22-007625.txt : 20220711
0001415889-22-007625.hdr.sgml : 20220711
20220711163020
ACCESSION NUMBER: 0001415889-22-007625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220707
FILED AS OF DATE: 20220711
DATE AS OF CHANGE: 20220711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DWEK RAYMOND
CENTRAL INDEX KEY: 0001231617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 221077231
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-07112022_040701.xml
X0306
4
2022-07-07
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231617
DWEK RAYMOND
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
Common Stock
2022-07-08
4
M
0
2160
0
A
2160
D
Common Stock
2022-07-11
4
S
0
2160
241.29
D
0
D
Restricted Stock Unit
0
2022-07-08
4
M
0
2160
0
D
2022-07-08
Common Stock
2160
0
D
Restricted Stock Unit
0
2022-07-07
4
A
0
1750
0
A
2023-07-07
Common Stock
1750
1750
D
Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
Annual non-employee director award.
/s/ John S. Hess, Jr. under Power of Attorney
2022-07-08